Amalgamated Bank Abbott Laboratories Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Abbott Laboratories stock. As of the latest transaction made, Amalgamated Bank holds 343,583 shares of ABT stock, worth $40.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

343,583

Previous 350,801 2.06%

Holding current value

$40.3 Million

Previous $36.5 Million 7.46%

% of portfolio

0.32%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $722,305 - $852,662	-7,218 Reduced 2.06%	343,583 $39.2 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $966,202 - $1.08 Million	-9,592 Reduced 2.66%	350,801 $36.5 Million
Q1 2024 Apr 23, 2024	SELL	$109.52 - $120.96 $6.44 Million - $7.11 Million	-58,816 Reduced 14.03%	360,393 $41 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $1.86 Million - $2.28 Million	-20,617 Reduced 4.69%	419,209 $46.1 Million
Q3 2023 Nov 08, 2023	SELL	$95.53 - $114.62 $1.34 Million - $1.61 Million	-14,055 Reduced 3.1%	439,826 $42.6 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $882,328 - $983,098	-8,755 Reduced 1.89%	453,881 $49.5 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $709,790 - $835,465	7,328 Added 1.61%	462,636 $46.8 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $2.11 Million - $2.48 Million	-22,203 Reduced 4.65%	455,308 $50 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $3.31 Million - $3.83 Million	34,181 Added 7.71%	477,511 $46.2 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $4.12 Million - $4.98 Million	-40,405 Reduced 8.35%	443,330 $48.2 Million
Q1 2022 Jun 30, 2022	SELL	$114.02 - $139.04 $606,586 - $739,692	-5,320 Reduced 1.09%	483,735 $57.3 Million
Q4 2021 Feb 15, 2022	BUY	$115.53 - $141.46 $6.25 Million - $7.66 Million	54,132 Added 12.45%	489,055 $68.8 Million
Q3 2021 Oct 29, 2021	SELL	$116.66 - $129.06 $1.99 Million - $2.2 Million	-17,047 Reduced 3.77%	434,923 $51.4 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $37.3 Million - $43.9 Million	352,398 Added 353.91%	451,970 $52.4 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $446,570 - $526,127	-4,103 Reduced 3.96%	99,572 $11.9 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $35,070 - $38,216	-334 Reduced 0.32%	103,675 $11.4 Million
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $237,439 - $288,352	-2,591 Reduced 2.43%	104,009 $11.3 Million
Q2 2020 Aug 10, 2020	SELL	$76.57 - $98.0 $12.3 Million - $15.8 Million	-161,190 Reduced 60.19%	106,600 $9.75 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $579,326 - $847,132	-9,222 Reduced 3.33%	267,790 $21.1 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $1.15 Million - $1.28 Million	14,614 Added 5.57%	277,012 $24.1 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $1.83 Million - $1.99 Million	22,370 Added 9.32%	262,398 $22 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $1.53 Million - $1.78 Million	20,977 Added 9.58%	240,028 $20.2 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $470,890 - $569,306	7,111 Added 3.36%	219,051 $17.5 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $255,880 - $289,875	-3,903 Reduced 1.81%	211,940 $15.3 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $322,961 - $389,614	-5,311 Reduced 2.4%	215,843 $15.8 Million
Q2 2018 Jul 18, 2018	BUY	$57.57 - $63.54 $562,631 - $620,976	9,773 Added 4.62%	221,154 $13.5 Million
Q1 2018 May 22, 2018	SELL	$56.27 - $63.62 $147,821 - $167,129	-2,627 Reduced 1.23%	211,381 $12.7 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $1.02 Million - $1.09 Million	18,991 Added 9.74%	214,008 $12.2 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $9.37 Million - $10.5 Million	195,017	195,017 $10.4 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Abbott Laboratories Transaction History